RHUMBLINE ADVISERS - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$67,000
+6.3%
30,689
+8.6%
0.00%
Q4 2020$63,000
-7.4%
28,264
+11.1%
0.00%
Q3 2020$68,000
-29.9%
25,434
-20.0%
0.00%
Q2 2020$97,000
+61.7%
31,799
+3.3%
0.00%
Q1 2020$60,000
-31.8%
30,7980.0%0.00%
Q4 2019$88,000
-12.0%
30,798
+12.7%
0.00%
Q3 2019$100,000
-11.5%
27,330
+0.3%
0.00%
Q2 2019$113,000
+91.5%
27,255
+53.5%
0.00%
Q1 2015$59,000
+18.0%
17,755
+23.7%
0.00%
Q4 2014$50,000
-28.6%
14,355
+3.1%
0.00%
Q3 2014$70,000
-63.5%
13,9300.0%0.00%
-100.0%
Q2 2014$192,00013,9300.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders